Psychosocial Risk Factors for Alzheimer’s Disease in Patients with Down Syndrome and Their Association with Brain Changes: A Narrative Review

被引:0
|
作者
Osama Hamadelseed
Ibrahim H. Elkhidir
Thomas Skutella
机构
[1] University of Heidelberg,Department of Neuroanatomy, Institute of Anatomy and Cell Biology
[2] University of Khartoum,Faculty of Medicine
来源
Neurology and Therapy | 2022年 / 11卷
关键词
Alzheimer’s disease; Corpus callosum; Dementia; Down syndrome; Hippocampus; Psychosocial risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
Several recent epidemiological studies attempted to identify risk factors for Alzheimer’s disease. Age, family history, genetic factors (APOE genotype, trisomy 21), physical activity, and a low level of schooling are significant risk factors. In this review, we summarize the known psychosocial risk factors for the development of Alzheimer’s disease in patients with Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. We completed a comprehensive review of the literature on PubMed, Google Scholar, and Web of Science about psychosocial risk factors for Alzheimer’s disease, for Alzheimer’s disease in Down syndrome, and Alzheimer’s disease in Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. Alzheimer’s disease causes early pathological changes in individuals with Down syndrome, especially in the hippocampus and corpus callosum. People with Down syndrome living with dementia showed reduced volumes of brain areas affected by Alzheimer’s disease as the hippocampus and corpus callosum in association with cognitive decline. These changes occur with increasing age, and the presence or absence of psychosocial risk factors impacts the degree of cognitive function. Correlating Alzheimer’s disease biomarkers in Down syndrome and cognitive function scores while considering the effect of psychosocial risk factors helps us identify the mechanisms leading to Alzheimer’s disease at an early age. Also, this approach enables us to create more sensitive and relevant clinical, memory, and reasoning assessments for people with Down syndrome.
引用
收藏
页码:931 / 953
页数:22
相关论文
共 50 条
  • [21] Association between Inflammatory Conditions and Alzheimer's Disease Age of Onset in Down Syndrome
    Lai, Florence
    Mercaldo, Nathaniel
    Wang, Cassandra M.
    Hersch, Giovi G.
    Rosas, Herminia Diana
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [22] Challenges faced in managing dementia in Alzheimer's disease in patients with Down syndrome
    Prasher, Vee P.
    Mahmood, Hassan
    Mitra, Madhumanti
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2016, 6 : 85 - 93
  • [23] Blood Biomarkers for Alzheimer's Disease in Down Syndrome
    Montoliu-Gaya, Laia
    Strydom, Andre
    Blennow, Kaj
    Zetterberg, Henrik
    Ashton, Nicholas James
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [24] Thyroid stimulating hormone - Receptor overexpression in brain of patients with Down Syndrome and Alzheimer's disease
    Labudova, O
    Cairns, N
    Koeck, T
    Kitzmueller, E
    Rink, H
    Lubec, G
    LIFE SCIENCES, 1999, 64 (12) : 1037 - 1044
  • [25] Complement dysregulation and Alzheimer's disease in Down syndrome
    Veteleanu, Aurora
    Pape, Sarah
    Davies, Kate
    Kodosaki, Eleftheria
    Hye, Abdul
    Zelek, Wioleta M.
    Strydom, Andre
    Morgan, B. Paul
    ALZHEIMERS & DEMENTIA, 2023, 19 (04) : 1383 - 1392
  • [26] Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review
    Petersen, Melissa E.
    O'Bryant, Sid E.
    DEVELOPMENTAL NEUROBIOLOGY, 2019, 79 (07) : 699 - 710
  • [27] Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome
    Iulita, M. Florencia
    Bejanin, Alexandre
    Vilaplana, Eduard
    Carmona-Iragui, Maria
    Benejam, Bessy
    Videla, Laura
    Barroeta, Isabel
    Fernandez, Susana
    Altuna, Miren
    Pegueroles, Jordi
    Montal, Victor
    Valldeneu, Silvia
    Gimenez, Sandra
    Gonzalez-Ortiz, Sofia
    Torres, Soraya
    El Bennadi, Shaimaa El Bounasri
    Padilla, Concepcion
    Aranha, Mateus Rozalem
    Estelles, Teresa
    Illan-Gala, Ignacio
    Belbin, Olivia
    Valle-Tamayo, Natalia
    Camacho, Valle
    Blessing, Esther
    Osorio, Ricardo S.
    Videla, Sebastian
    Lehmann, Sylvain
    Holland, Anthony J.
    Zetterberg, Henrik
    Blennow, Kaj
    Alcolea, Daniel
    Clarimon, Jordi
    Zaman, Shahid H.
    Blesa, Rafael
    Lleo, Alberto
    Fortea, Juan
    BRAIN COMMUNICATIONS, 2023, 5 (02)
  • [28] Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer's Disease in Down Syndrome
    Beresford-Webb, Jessica A.
    Mcallister, Catherine J.
    Sleigh, Alison
    Walpert, Madeleine J.
    Holland, Anthony J.
    Zaman, Shahid H.
    BRAIN SCIENCES, 2025, 15 (02)
  • [29] Decoding brain structure to stage Alzheimer's disease pathology in Down syndrome
    Kennedy, James T.
    Wisch, Julie K.
    Dincer, Aylin
    Roman, June
    Gordon, Brian A.
    Handen, Benjamin
    Benzinger, Tammie L. S.
    Head, Elizabeth
    Mapstone, Mark
    Christian, Bradley T.
    Tudorascu, Dana L.
    Laymon, Charles L.
    Hartley, Sigan L.
    Lao, Patrick
    Brickman, Adam M.
    Zaman, Shahid H.
    Ances, Beau M.
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [30] Does resistance training in older adults lead to structural brain changes associated with a lower risk of Alzheimer's dementia? A narrative review
    Nicola, Louisa
    Loo, Stephanie Jyet Quan
    Lyon, Gabrielle
    Turknettx, Josh
    Wood, Thomas R.
    AGEING RESEARCH REVIEWS, 2024, 98